Rezvilutamide for metastatic hormone-sensitive prostate cancer

被引：0
|
作者：
Ye, Dingwei [1 ,2 ]
Gu, Weijie [1 ,2 ]
Li, Junliang [3 ]
机构：
[1] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China
[3] Jiangsu Hengrui Pharmaceut, Clin Res & Dev, Shanghai, Peoples R China
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E491 / E491
页数：1
相关论文
共 50 条
  • [1] Rezvilutamide: yet another androgen receptor pathway inhibitor for metastatic hormone-sensitive prostate cancer?
    Aragon-Ching, Jeanny B.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (02)
  • [2] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [3] Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer
    Ding, Haiying
    Li, Shujing
    Xu, Xinglu
    Xu, Weiben
    He, Chaoneng
    Xin, Wenxiu
    Zhan, ZhaJun
    Fang, Luo
    BMJ OPEN, 2024, 14 (07): : 1 - 6
  • [4] Case report and literature review of rezvilutamide in the treatment of hormone-sensitive prostate cancer
    Zhang, Chunlei
    Ren, Jie
    Kang, Yindong
    Chang, Dehui
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [6] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [7] Correlation of PSA and survival in metastatic hormone-sensitive prostate cancer treated with rezvilutamide plus ADT in the CHART trial
    Bian, Xiaojie
    Gu, Weijie
    Zhang, Xuepei
    Xie, Liping
    Wang, Shaogang
    Shi, Benkang
    Sun, Ting
    Wei, Shaozhong
    Weng, Zhiliang
    Xia, Shujie
    Han, Bangmin
    Xu, Zhuoqun
    Xing, Jinchun
    Zhang, Dahong
    Xu, Danfeng
    Du, Chuanjun
    He, Chaohong
    Wang, Qilin
    Yang, Xinfeng
    Lian, Jianpo
    Wang, Wenliang
    Ye, Dingwei
    MED, 2025, 6 (02):
  • [8] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [9] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [10] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
12345